Frannie Uvenio Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-1361 |
Sara Durham Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-943-5656 Fax: 973-543-1361 |
Rebecca Ouellette Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 |
Tyler Artress Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-1361 |
Noel Akers Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 West Main Street, Mendham, NJ 07945 Phone: 973-543-5656 |
Mr. Kevin C Shoemaker Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-1361 |
Ms. Debra Weinberger Brafman, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5 Cold Hill Rd S, Mendham, NJ 07945 Phone: 973-543-2036 |
Timothy Wever Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-1361 |
Paula Rachelle Barber, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 32 Pembroke Dr, Mendham, NJ 07945 Phone: 973-879-3821 |
Patrick Mullen Kelly, MA, LAC, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6 Jane Ter, Mendham, NJ 07945 Phone: 973-452-3348 |
Jan F Kerr Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 |
Christopher Waters, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 85a E Main St, Mendham, NJ 07945 Phone: 972-306-4802 |
Josephine Ann Cleary Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 West Main Street, Mendham, NJ 07945 Phone: 973-543-5656 |
Mr. Scott Ryan Magill Iii Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 |
Mrs. Colette Elizabeth Cerrato, MA Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 |
Ms. Eileen S Hennessey Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-1361 |
Ms. Mary Elizabeth Fennelly, CRC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W. Main Street, Mendham, NJ 07945 Phone: 973-543-5656 |
Connor Wills Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 |
Jalen Washington Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-1361 |
Mr. Melvin Dangan Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 80 W Main St, Mendham, NJ 07945 Phone: 973-543-5656 Fax: 973-543-5273 |
News Archive
The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.
Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
Rapamycin, an immunosuppressant drug used in a variety of disease indications and under study in aging research labs around the world, improved function and extended survival in mice suffering from a genetic mutation which leads to dilated cardiomyopathy (DCM) and rare muscular dystrophies in humans.
A molecule known as ACE2 sits like a doorknob on the outer surfaces of the cells that line the lungs. Since January 2020, researchers have known that SARS-CoV-2, the novel coronavirus that causes COVID-19, primarily uses ACE2 to enter these cells and establish respiratory infections.
› Verified 7 days ago